We are live on ! Find out more
GKIM

GW&K Investment Management Portfolio holdings

AUM $12.8B
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
-1.98%
1 Year Est. Return
+48.82%
3 Year Est. Return
+110.09%
5 Year Est. Return
+134.03%
10 Year Est. Return
+612.52%
AUM
$9.06B
AUM Growth
-$208M
Cap. Flow
+$200M
Cap. Flow %
2.21%
Top 10 Hldgs %
12.14%
Holding
854
New
14
Increased
123
Reduced
229
Closed
455

Sector Composition

Rank Sector Weight
1 Industrials 16.92%
2 Healthcare 16.87%
3 Technology 15.88%
4 Financials 12.87%
5 Consumer Discretionary 11.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PPBI
101
DELISTED
Pacific Premier Bancorp
PPBI
$39M 0.43%
1,260,595
-99,474
-7% -$3.24M
CHX
102
DELISTED
ChampionX
CHX
$38.4M 0.42%
1,963,112
+580,204
+42% +$12M
WSO icon
103
Watsco Inc
WSO
$12.8B
$38.1M 0.42%
148,069
-1,268
-0.8% -$344K
OXM icon
104
Oxford Industries
OXM
$538M
$37.6M 0.42%
419,272
-35,021
-8% -$3.39M
NWE icon
105
NorthWestern Energy
NWE
$4.34B
$37.5M 0.41%
760,690
-71,374
-9% -$3.92M
HMN icon
106
Horace Mann Educators
HMN
$2.09B
$37.5M 0.41%
1,061,451
+156,898
+17% +$5.65M
MTN icon
107
Vail Resorts
MTN
$5.29B
$36.7M 0.41%
170,390
+63,316
+59% +$14.4M
ITGR icon
108
Integer Holdings
ITGR
$4.25B
$36.7M 0.4%
589,499
+44,507
+8% +$2.99M
POR icon
109
Portland General Electric
POR
$5.74B
$35.7M 0.39%
822,249
+78,058
+10% +$3.99M
BIO icon
110
Bio-Rad Laboratories Class A
BIO
$9.68B
$35.6M 0.39%
85,306
+12,447
+17% +$6.21M
NOVT icon
111
Novanta
NOVT
$6.32B
$35.5M 0.39%
307,181
-113,365
-27% -$15.4M
AAP icon
112
Advance Auto Parts
AAP
$3.23B
$35.4M 0.39%
226,457
+404
+0.2% +$73.8K
CCXI
113
DELISTED
ChemoCentryx, Inc.
CCXI
$35.3M 0.39%
683,702
-853,175
-56% -$35.3M
PHR icon
114
Phreesia
PHR
$758M
$35.3M 0.39%
1,383,490
-48,708
-3% -$1.22M
DOC
115
DELISTED
PHYSICIANS REALTY TRUST
DOC
$34.8M 0.38%
2,314,169
+217,117
+10% +$3.67M
ATRC icon
116
AtriCure
ATRC
$2.22B
$34.4M 0.38%
879,541
+57,783
+7% +$2.64M
DEA
117
Easterly Government Properties
DEA
$1.16B
$34.1M 0.38%
865,459
+82,169
+10% +$3.8M
WFC icon
118
Wells Fargo
WFC
$269B
$33.9M 0.37%
842,151
-7,765
-0.9% -$334K
BURL icon
119
Burlington
BURL
$22.3B
$33.7M 0.37%
300,909
+44,328
+17% +$6.46M
HOLX
120
DELISTED
Hologic
HOLX
$33.4M 0.37%
517,054
+46,802
+10% +$3.24M
CRI icon
121
Carter's
CRI
$1.43B
$33.1M 0.37%
505,400
+192,384
+61% +$14.7M
IART icon
122
Integra LifeSciences
IART
$1.35B
$32.5M 0.36%
767,386
-4,214
-0.5% -$216K
OCFC icon
123
OceanFirst Financial
OCFC
$1.85B
$31.9M 0.35%
1,711,894
-161,443
-9% -$3.23M
SHYF
124
DELISTED
The Shyft Group
SHYF
$31.5M 0.35%
1,543,953
+226,507
+17% +$5.28M
CENTA icon
125
Central Garden & Pet Co Class A
CENTA
$2.43B
$31.5M 0.35%
1,153,375
-113,543
-9% -$3.56M

Similar funds

GW&K Investment Management's Q3 2022 Portfolio in Review

As of Q3 2022, GW&K Investment Management held 854 positions worth $9.06B, down 2.2% from $9.27B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

GW&K Investment Management's Q3 2022 filing shows 14 new, 123 increased, 229 reduced and 455 closed positions. Its largest new stake was Lincoln Electric: 236,966 shares worth $29.8M. The largest sale was ChemoCentryx, Inc., an estimated $35.3M.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.

  • GW&K Investment Management's largest Q3 2022 buy was Lincoln Electric: 236,966 shares worth $29.8M.
  • GW&K Investment Management added most to Intra-Cellular Therapies Inc. in Q3 2022, an estimated $46.1M increase.
  • GW&K Investment Management's biggest Q3 2022 reduction was ChemoCentryx, Inc., cutting an estimated $35.3M.
  • GW&K Investment Management fully exited PS Business Parks, Inc. in Q3 2022, selling an estimated $30.9M.
  • GW&K Investment Management's ten largest holdings make up 12% of its $9.06B portfolio in Q3 2022.
  • GW&K Investment Management opened 14 new positions and closed 455 in Q3 2022.
  • GW&K Investment Management's portfolio value fell 2.2% quarter-over-quarter to $9.06B.

Based on GW&K Investment Management's 13F filing for Q3 2022, filed 9 Nov 2022.